Condition
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer clinical trials that are recruiting, in China. By phase: Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Dual-target PSMA/PSCA CAR-NK Therapy in Advanced Prostate Cancer
This trial tests ETB-DualNK-01, a dual-target CAR-NK cell therapy, in adults with metastatic castration-resistant prostate cancer to see if it is safe and shows early signs of activity.
-
HRS-4357 versus novel androgen receptor pathway inhibitors for PSMA-positive metastatic castration-resistant prostate cancer
This trial will test whether HRS-4357 works better than newer androgen receptor pathway drugs (like enzalutamide or abiraterone) for men with PSMA-positive metastatic castration-resistant prostate cancer.
Related topics
Quick answers
How many PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.